- Home
- VKTX vs BGSI Comparison
VKTX vs BGSI Comparison
Compare VKTX & BGSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VKTX | BGSI |
|---|---|---|
| Founded | 2012 | 1990 |
| Country | United States | Canada |
| Employees | N/A | 13449 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.5B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | VKTX | BGSI |
|---|---|---|
| Price | $28.75 | $95.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | $95.86 | ★ $157.00 |
| AVG Volume (30 Days) | ★ 1.9M | 39.6K |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $35.07 |
| Revenue Next Year | N/A | $8.01 |
| P/E Ratio | ★ N/A | $231.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.96 | $93.79 |
| 52 Week High | $43.15 | $183.10 |
Technical Indicators
Market Signals| Indicator | VKTX | BGSI |
|---|---|---|
| Relative Strength Index (RSI) | 43.67 | 31.02 |
| Support Level | $25.77 | $94.77 |
| Resistance Level | $32.92 | $110.36 |
| Average True Range (ATR) | 1.29 | 3.31 |
| MACD | -0.11 | -0.42 |
| Stochastic Oscillator | 30.67 | 8.74 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About BGSI Boyd Group Services Inc.
Boyd Group Services Inc is engaged in operating non-franchised collision repair centers in North America. The Company's primary line of business is automotive collision and glass repair and related services, with the majority of revenues relating to this group of similar services. This line of business operates in Canada and the U.S. and both regions exhibit similar long-term economic characteristics. he Company is also a retail auto glass operator in the United States, under the trade names Gerber Collision & Glass, Glass America, Auto Glass Service, Auto Glass Authority. The company has majority of its sales from USA.